Results 271 to 280 of about 268,538 (298)

2 Inhibitiors of Angiotensin-Converting Enzyme

1980
Publisher Summary This chapter focuses on the development, mechanism of action, and biological activity of two distinct classes of therapeutically useful inhibitors of angiotensin-converting enzyme: the snake venom peptides and a newly developed class of orally active inhibitors that were designed for specific binding to the active site of this ...
David W. Cushman, Miguel A. Ondetti
openaire   +3 more sources

Angiotensin converting enzyme inhibitors in pregnancy

Seminars in Perinatology, 1997
Angiotensin converting enzyme (ACE) inhibitors are excellent antihypertensive agents and are becoming widely used as first-line therapy for chronic hypertension in women of reproductive age owing to their efficacy and few side effects. Reports of adverse fetal and neonatal effects from the use of ACE inhibitors in pregnancy in both animal and human ...
openaire   +3 more sources

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

The Lancet, 2003
J. McMurray, J. Östergren, K. Swedberg, C. Granger, P. Held, E. Michelson, B. Olofsson, S. Yusuf, M. Pfeffer   +8 more
semanticscholar   +1 more source

Overview of the angiotensin-converting-enzyme inhibitors

American Journal of Health-System Pharmacy, 2000
The pharmacology of angiotensin-converting-enzyme (ACE) inhibitors and their role in the renin-angiotensin system (RAS) are described, and pharmacokinetic properties and common adverse events are presented. ACE inhibitors play a vital role in the RAS by regulating the potent vasoconstrictor angiotensin II.
openaire   +3 more sources

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

The Lancet, 2003
C. Granger, J. McMurray, S. Yusuf, P. Held, E. Michelson, B. Olofsson, J. Östergren, M. Pfeffer, K. Swedberg   +8 more
semanticscholar   +1 more source

Angiotensin‐Converting enzyme inhibitors

Medical Journal of Australia, 1994
openaire   +6 more sources

Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort

Anesthesiology, 2017
P. Roshanov, B. Rochwerg, Ameen Patel, O. Salehian, E. Duceppe, E. Belley‐Cote, G. Guyatt, D. Sessler, Y. Le Manach, F. Borges, V. Tandon, A. Worster, Alexandra N Thompson, M. Koshy, B. Devereaux, F. Spencer, R. Sanders, Erin N. Sloan, Erin E. Morley, J. Paul, K. Raymer, Z. Punthakee, P. Devereaux   +22 more
semanticscholar   +1 more source

Angiotensin-converting enzyme inhibitors

Journal of the American Academy of Dermatology, 1993
Anil Abraham, Eugene M. Farber
openaire   +4 more sources

Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?

Journal of the American College of Cardiology, 2018
F. Messerli, S. Bangalore, Chirag P Bavishi, S. Rimoldi   +3 more
semanticscholar   +1 more source

Inhibitors of Angiotensin-Converting Enzyme

1980
H S Cheung, Antonaccio Mj, Miguel A. Ondetti, Murthy Vs, Bernard Rubin, David W. Cushman   +5 more
openaire   +3 more sources